Literature DB >> 24879551

Factors associated with pressure ulcer risk in spinal cord injury rehabilitation.

Gerben DeJong1, Ching-Hui J Hsieh, Patrick Brown, Randall J Smout, Susan D Horn, Pamela Ballard, Tara Bouchard.   

Abstract

OBJECTIVE: The aim of this study was to identify patient and clinical factors most strongly associated with a spinal cord injury patient's risk for developing a pressure ulcer (PU) during rehabilitation.
DESIGN: This is a prospective observational cohort study conducted at an urban rehabilitation hospital-based specialized spinal cord injury center. The main outcome measure was the onset of a stage 2 or higher PU.
RESULTS: Study patients (N = 159) with new (n = 66) and patients with earlier (n = 99) spinal injuries had identical rates at which they acquired a new PU (stage ≥2) in rehabilitation--13.1%. The patients who came to rehabilitation with a PU or myocutaneous flap exhibited a higher rate of developing yet another PU while in rehabilitation (30.2%) than those who came to rehabilitation without an existing PU or flap (6.9%). Logistic regression analysis identified two variables that best predicted a patient's risk at admission for developing a PU during rehabilitation (c = 0.77)--entering rehabilitation with a PU and admission Functional Independence Measure transfers score of less than 3.5.
CONCLUSIONS: The greatest risk of developing a new PU in rehabilitation is being admitted with an existing PU followed by admission Functional Independence Measure transfers score of less than 3.5. Using these two variables, one can develop a patient PU risk algorithm at admission that can alert clinicians for the need to enhance vigilance, skin monitoring, and early patient education.

Entities:  

Mesh:

Year:  2014        PMID: 24879551     DOI: 10.1097/PHM.0000000000000117

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

1.  A latent structural equation model of protective behaviors and pressure ulcer outcomes among people living with spinal cord injury.

Authors:  C Li; N D DiPiro; J Krause
Journal:  Spinal Cord       Date:  2016-11-29       Impact factor: 2.772

2.  The association between metabolic syndrome and pressure ulcers among individuals living with spinal cord injury.

Authors:  C Li; N D DiPiro; Y Cao; Y Szlachcic; J Krause
Journal:  Spinal Cord       Date:  2016-04-19       Impact factor: 2.772

3.  Nonnegative matrix factorization for the identification of pressure ulcer risks from seating interface pressures in people with spinal cord injury.

Authors:  Tim D Yang; Yih-Kuen Jan
Journal:  Med Biol Eng Comput       Date:  2019-12-12       Impact factor: 2.602

4.  Using clinical data to predict high-cost performance coding issues associated with pressure ulcers: a multilevel cohort model.

Authors:  William V Padula; Robert D Gibbons; Peter J Pronovost; Donald Hedeker; Manish K Mishra; Mary Beth F Makic; John Fp Bridges; Heidi L Wald; Robert J Valuck; Adam J Ginensky; Anthony Ursitti; Laura Ruth Venable; Ziv Epstein; David O Meltzer
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

5.  Visualization of user interactions with a pressure mapping mobile application for wheelchair users at risk for pressure injuries.

Authors:  Brianna M Goodwin; Christine M Olney; John E Ferguson; Andrew H Hansen; Byron Eddy; Gary Goldish; Melissa M Morrow; Tamara L Vos-Draper
Journal:  Assist Technol       Date:  2021-03-11

6.  The global burden of pressure ulcers among patients with spinal cord injury: a systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Henok Mulugeta; Yared Asmare Aynalem
Journal:  BMC Musculoskelet Disord       Date:  2020-05-29       Impact factor: 2.362

7.  Exploring the first pressure injury and characteristics of subsequent pressure injury accrual following spinal cord injury.

Authors:  Alexandra E Harper; Lauren Terhorst; David Brienza; Natalie E Leland
Journal:  J Spinal Cord Med       Date:  2020-04-01       Impact factor: 1.985

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.